Adhering to the innovative spirit of Sincerity for Ambition, the Kanion research institute is devoted to research on standardization, intelligence, and internationalization of TCM.

    Guided by TCM theory and focus on the advantageous areas of Chinese medicine applied the cutting-edge and advanced technology of modern medicine research and development, Kanion will research and develop innovative Chinese medicine drugs with a clearer material basis and mechanism, more refined preparations, and more precise indications, to promote the development of TCM.

    Founded in 1991, after more than 30 years of development and accumulation of innovation, the research institute has built national postdoctoral research stations, nationally accredited enterprise technology centers, the National Local Joint Engineering Research Centre for Intelligent Manufacturing Technology of Proprietary Chinese Medicines, the National Key Laboratory of Pharmaceutical Process Control and Intelligent Manufacturing Technology of Traditional Chinese Medicines, and other state-level scientific research platforms.

    With R&D centers in Lianyungang, Nanjing, Shanghai, and other places in Jiangsu Province, the institute has a systematic R&D platform for the whole process of innovative Chinese medicine discovery-new drug R&D- re-evaluation of post-market.

    The total area of the research institute is 50,000 square metres which owns RMB 229 million value for advanced instruments and equipment.

    Kanion has been ranked No.1 in China TCM R&D Strength Ranking for many years in terms of scientific research and innovation for its over 10% R&D investment for research platforms, technological innovation, and product development.